Literature DB >> 25914471

Surgical procedure determination based on tumor-node-metastasis staging of gallbladder cancer.

Xiao-Dong He1, Jing-Jing Li1, Wei Liu1, Qiang Qu1, Tao Hong1, Xie-Qun Xu1, Bing-Lu Li1, Ying Wang1, Hai-Tao Zhao1.   

Abstract

AIM: To investigate the impact of surgical procedures on prognosis of gallbladder cancer patients classified with the latest tumor-node-metastasis (TNM) staging system.
METHODS: A retrospective study was performed by reviewing 152 patients with primary gallbladder carcinoma treated at Peking Union Medical College Hospital from January 2003 to June 2013. Postsurgical follow-up was performed by telephone and outpatient visits. Clinical records were reviewed and patients were grouped based on the new edition of TNM staging system (AJCC, seventh edition, 2010). Prognoses were analyzed and compared based on surgical operations including simple cholecystectomy, radical cholecystectomy (or extended radical cholecystectomy), and palliative surgery. Simple cholecystectomy is, by definition, resection of the gallbladder fossa. Radical cholecystectomy involves a wedge resection of the gallbladder fossa with 2 cm non-neoplastic liver tissue; resection of a suprapancreatic segment of the extrahepatic bile duct and extended portal lymph node dissection may also be considered based on the patient's circumstance. Palliative surgery refers to cholecystectomy with biliary drainage. Data analysis was performed with SPSS 19.0 software. Kaplan-Meier survival analysis and Logrank test were used for survival rate comparison. P < 0.05 was considered statistically significant.
RESULTS: Patients were grouped based on the new 7(th) edition of TNM staging system, including 8 cases of stage 0, 10 cases of stage I, 25 cases of stage II, 21 cases of stage IIIA, 21 cases of stage IIIB, 24 cases of stage IVA, 43 cases of stage IVB. Simple cholecystectomy was performed on 28 cases, radical cholecystectomy or expanded gallbladder radical resection on 57 cases, and palliative resection on 28 cases. Thirty-nine cases were not operated. Patients with stages 0 and I disease demonstrated no statistical significant difference in survival time between those receiving radical cholecystectomy and simple cholecystectomy (P = 0.826). The prognosis of stage II patients with radical cholecystectomy was better than that of simple cholecystectomy. For stage III patients, radical cholecystectomy was significantly superior to other surgical options (P < 0.05). For stage IVA patients, radical cholecystectomy was not better than palliative resection and non-surgical treatment. For stage IVB, patients who underwent palliative resection significantly outlived those with non-surgical treatment (P < 0.01)
CONCLUSION: For stages 0 and I patients, simple cholecystectomy is the optimal surgical procedure, while radical cholecystectomy should be actively operated for stages II and III patients.

Entities:  

Keywords:  Gallbladder cancer; Prognosis; Radical cholecystectomy; Simple cholecystectomy; Tumor-node-metastasis staging

Mesh:

Year:  2015        PMID: 25914471      PMCID: PMC4402309          DOI: 10.3748/wjg.v21.i15.4620

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  26 in total

1.  Hepatobiliary cancers. Clinical practice guidelines in oncology.

Authors:  Al B Benson; Tanios Bekaii-Saab; Edgar Ben-Josef; Leslie Blumgart; Bryan M Clary; Steven A Curley; Rene Davila; Craig C Earle; William D Ensminger; John F Gibbs; Daniel Laheru; Alan N Langnas; Sean J Mulvihill; Albert A Nemcek; James A Posey; Elin R Sigurdson; Mika Sinanan; Jean-Nicolas Vauthey; Alan P Venook; Lawrence D Wagman; Timothy J Yeatman
Journal:  J Natl Compr Canc Netw       Date:  2006-09       Impact factor: 11.908

2.  Incidence pattern and survival for gallbladder cancer over three decades--an analysis of 10301 patients.

Authors:  R P Kiran; N Pokala; S J Dudrick
Journal:  Ann Surg Oncol       Date:  2006-11-16       Impact factor: 5.344

Review 3.  Evolving treatment strategies for gallbladder cancer.

Authors:  Matthew T Hueman; Charles M Vollmer; Timothy M Pawlik
Journal:  Ann Surg Oncol       Date:  2009-06-03       Impact factor: 5.344

4.  Comparison of the sixth and seventh editions of the AJCC TNM classification for gallbladder cancer.

Authors:  Tak Geun Oh; Moon Jae Chung; Seungmin Bang; Seung Woo Park; Jae Bok Chung; Si Young Song; Gi Hong Choi; Kyung Sik Kim; Woo Jung Lee; Jeong Youp Park
Journal:  J Gastrointest Surg       Date:  2013-01-09       Impact factor: 3.452

5.  Is extended hemihepatectomy plus pancreaticoduodenectomy justified for advanced bile duct cancer and gallbladder cancer?

Authors:  Yoshihiro Sakamoto; Satoshi Nara; Yoji Kishi; Minoru Esaki; Kazuaki Shimada; Norihiro Kokudo; Tomoo Kosuge
Journal:  Surgery       Date:  2013-02-13       Impact factor: 3.982

6.  Predictors of long-term survival in patients with gallbladder cancer.

Authors:  Palat Balachandran; Shaleen Agarwal; Narendra Krishnani; Chandra M Pandey; Ashok Kumar; Sadiq S Sikora; Rajan Saxena; Vinay K Kapoor
Journal:  J Gastrointest Surg       Date:  2006-06       Impact factor: 3.452

Review 7.  Should preoperative biliary drainage be routinely performed for obstructive jaundice with resectable tumor?

Authors:  Chu Wang; Yiyao Xu; Xin Lu
Journal:  Hepatobiliary Surg Nutr       Date:  2013-10       Impact factor: 7.293

8.  A critical analysis of the surgical management of early-stage gallbladder cancer in the United States.

Authors:  Eric H Jensen; Anasooya Abraham; Elizabeth B Habermann; Waddah B Al-Refaie; Selwyn M Vickers; Beth A Virnig; Todd M Tuttle
Journal:  J Gastrointest Surg       Date:  2008-12-13       Impact factor: 3.452

9.  Extended hepatic resection for gallbladder cancer.

Authors:  Srinevas K Reddy; Carlos E Marroquin; Paul C Kuo; Theodore N Pappas; Bryan M Clary
Journal:  Am J Surg       Date:  2007-09       Impact factor: 2.565

10.  Analysis of the relationships between clinicopathologic factors and survival in gallbladder cancer following surgical resection with curative intent.

Authors:  Xin-wei Yang; Jue Yang; Liang Li; Xiao-bo Man; Bao-hua Zhang; Feng Shen; Meng-chao Wu
Journal:  PLoS One       Date:  2012-12-31       Impact factor: 3.240

View more
  3 in total

Review 1.  To Resect or Not to Resect Extrahepatic Bile Duct in Gallbladder Cancer?

Authors:  Paschalis Gavriilidis; Alan Askari; Daniel Azoulay
Journal:  J Clin Med Res       Date:  2016-12-31

2.  Site-specific metastases of gallbladder adenocarcinoma and their prognostic value for survival: a SEER-based study.

Authors:  Yingnan Yang; Zhuolong Tu; Chentao Ye; Huajie Cai; Shouzhang Yang; Xuehai Chen; Jinfu Tu
Journal:  BMC Surg       Date:  2021-01-23       Impact factor: 2.102

3.  Trends in Treatment and Survival of Gallbladder Cancer in the Netherlands; Identifying Gaps and Opportunities from a Nation-Wide Cohort.

Authors:  Elise de Savornin Lohman; Tessa de Bitter; Rob Verhoeven; Lydia van der Geest; Jeroen Hagendoorn; Nadia Haj Mohammad; Freek Daams; Heinz-Josef Klümpen; Thomas van Gulik; Joris Erdmann; Marieke de Boer; Frederik Hoogwater; Bas Groot Koerkamp; Andries Braat; Joanne Verheij; Iris Nagtegaal; Cornelis van Laarhoven; Peter van den Boezem; Rachel van der Post; Philip de Reuver
Journal:  Cancers (Basel)       Date:  2020-04-09       Impact factor: 6.639

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.